RESEARCH TRIANGLE PARK, N.C. and STAMFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, and BEKHealth, a number one scientific analysis platform, right this moment introduced a partnership that may allow Science 37 to entry the EMR knowledge, solely, throughout its community of greater than 35 thousand neighborhood suppliers, protecting greater than 35 million affected person lives–increasing participant entry, accelerating enrollment, and probably lowering time to marketplace for essential investigational remedies and therapies.
“As a digital web site, Science 37 is within the distinctive place to have the ability to entry sufferers which might be unavailable via a standard web site community,” stated Darcy Forman, Chief Supply Officer at Science 37. “Instantly accessing the EMR knowledge throughout our neighborhood suppliers allows us to get rather more exact at feasibility and to speed up enrollment via one in all our most prolific affected person recruitment channels.”
At present, lower than 3% of all suppliers are scientific analysis investigators. Given their restricted entry to sufferers, lower than 8% of sufferers are ever contacted to take part in scientific analysis. Through the use of BEKHealth’s A.I. know-how to go looking the digital medical information of sufferers inside Science 37’s in depth neighborhood supplier community, Science 37 can match particular person sufferers to particular scientific trial cohorts. This expands entry to incorporate sufferers who weren’t beforehand in a position to take part, growing each the amount of individuals and the pace of enrollment.
“We’re delighted to work with Science 37 to broaden entry to scientific trials, significantly inside under-represented communities,” stated Jason Baumgartner, President and CEO at BEKHealth. “By making use of our knowledge, know-how, and instruments to Science 37’s flourishing neighborhood supplier community, we’re in a position to assist their mission to supply entry to sufferers who would usually not have publicity to scientific analysis. With this partnership, we’ll be capable to goal the greater than 90% of sufferers in healthcare programs who’re historically neglected.”
About Science 37
Science 37, Inc.’s (Nasdaq: SNCE) mission is to speed up scientific analysis by enabling common entry for sufferers. In 2014, we pioneered decentralized scientific trials, and we proceed to steer, delivering sooner, extra inclusive, patient-centric trials, by eradicating boundaries to entry via a tech-enabled digital web site. The Science 37 Metasite™ leverages a unified set of individuals, processes, and know-how, delivering higher consistency and regulatory-quality knowledge. With essentially the most medical and operational expertise throughout therapeutic areas, Science 37 has enabled as much as 21x sooner enrollment, 28% higher retention, and 3x extra range vs. the standard web site. To be taught extra, go to www.science37.com, or e-mail science37@science37.com.
About BEKHealth
BEKHealth Company is a privately held, venture-backed enterprise primarily based in Connecticut. BEKHealth was based to serve a core want of scientific analysis—extra correct and automatic trial feasibility and affected person trial matching. By combining a proprietary AI-powered EMR data-processing engine with easy-to-use and impactful workflow options, we offer websites and CROs the flexibility to attain “the final mile” to recruit the appropriate sufferers extra quickly. For extra info, go to www.bekhealth.com.
Cautionary Word Relating to Ahead-Trying Statements
This press launch comprises sure forward-looking statements inside the which means of the federal securities legal guidelines, together with statements concerning the merchandise provided by Science 37, its gross sales pipeline and the markets wherein it operates. These forward-looking statements typically are recognized by the phrases “consider,” “mission,” “anticipate,” “anticipate,” “estimate,” “intend,” “technique,” “future,” “alternative,” “plan,” “could,” “ought to,” “will,” “would,” “will likely be,” “will proceed,” “will possible consequence” and comparable expressions. Ahead-looking statements are predictions, projections and different statements about future occasions which might be primarily based on present expectations and assumptions and, in consequence, are topic to dangers and uncertainties. Many components may trigger precise future occasions to vary materially from the forward-looking statements on this press launch, together with however not restricted to: (i) the flexibility to take care of the itemizing of Science 37’s securities on Nasdaq, (ii) volatility within the value of Science 37’s securities on account of a wide range of components, together with adjustments within the aggressive and extremely regulated industries wherein Science 37 operates, variations in efficiency throughout opponents, adjustments in legal guidelines and laws affecting Science 37’s enterprise and adjustments in its capital construction, (iii) the flexibility to implement enterprise plans, forecasts, and different expectations, and to establish and notice further alternatives, (iv) the danger that Science 37 could by no means obtain or maintain profitability, (v) the danger that Science 37 might want to elevate further capital to execute its marketing strategy, which is probably not obtainable on acceptable phrases or in any respect, (vi) failure to understand anticipated value financial savings, and (vii) the potential opposed results of the continuing international COVID-19 pandemic. The foregoing listing of things will not be exhaustive. You must rigorously take into account the foregoing components and the opposite dangers and uncertainties described within the “Danger Elements” part of our Annual Report on Kind 10-Okay for the fiscal 12 months ended December 31, 2021 filed with the U.S. Securities and Trade Fee (the “SEC”) on March 22, 2022 and in our different paperwork filed by Science 37 occasionally with the SEC. These filings establish and deal with different essential dangers and uncertainties that would trigger precise occasions and outcomes to vary materially from these contained within the forward-looking statements. Ahead-looking statements converse solely as of the date they’re made. Readers are cautioned to not put undue reliance on forward-looking statements, and Science 37 assumes no obligation and doesn’t intend to replace or revise these forward-looking statements, whether or not because of new info, future occasions, or in any other case, besides as required by legislation. Science 37 doesn’t give any assurance that Science 37 will obtain its expectations.
MEDIA INQUIRIES:
Grazia Mohren
Science 37
PR@science37.com
Greg Kalish
GKC for BEKHealth
gkalish@gkcomms.com
INVESTOR RELATIONS:
Steve Halper
LifeSci Advisors
Investors@science37.com
